ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      4,967.23
      -0.88%
      US Tech 100
      16,578.40
      -2.11%
      Dow Jones
      37,986.40
      0.56%
      Brent Oil
      86.625
      0.24%
      Bitcoin
      64,328.06
      1.29%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Y mAbs Therapeutics Inc (YMAB)

      7. Y mAbs Therapeutics Inc (YMAB) News

      YMAB Y mAbs Therapeutics Inc

      15.13
      0.13 (0.87%)
      After Hours
      Last Updated: 16:04:36
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Y mAbs Therapeutics Inc YMAB NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.13 0.87% 15.13 16:04:36
      Open Price Low Price High Price Close Price Prev Close
      14.85 14.7082 15.41 15.13 15.00
      more quote information »

      Recent News

      Date Time Source Heading
      3/14/202409:05GLOBEY-mAbs Therapeutics Announces Resignation of Chief Financial..
      3/07/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/07/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/06/202416:49EDGAR2Form 144 - Report of proposed sale of securities
      3/06/202416:40EDGAR2Form 144 - Report of proposed sale of securities
      3/05/202419:05EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202407:30GLOBEY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to..
      3/04/202406:05EDGAR2Form 8-K - Current report
      2/29/202417:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
      2/29/202416:05GLOBEY-mAbs Reports Fourth Quarter and Full Year 2023 Financial..
      2/29/202416:04EDGAR2Form 8-K - Current report
      2/16/202407:30GLOBEY-mAbs to Announce Fourth Quarter and Full Year 2023..
      2/14/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/06/202415:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/22/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202418:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202417:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202417:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202417:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/22/202417:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/09/202406:45EDGAR2Form 8-K - Current report
      1/02/202416:05GLOBEY-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan..
      12/26/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/15/202319:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/13/202316:40EDGAR2Form 144 - Report of proposed sale of securities
      12/13/202316:05GLOBEY-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
      12/12/202308:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/12/202308:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202317:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202317:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/01/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/01/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/29/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/29/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/22/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/20/202316:07EDGAR2Form 144 - Report of proposed sale of securities
      11/13/202316:47EDGAR2Form 8-K - Current report
      11/13/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202316:05GLOBEY-mAbs Reports Third Quarter 2023 Financial Results and..
      11/08/202317:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/08/202317:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
      10/31/202307:05GLOBEY-mAbs to Announce Third Quarter 2023 Financial and..
      10/18/202316:09EDGAR2Form 8-K - Current report
      10/18/202316:05GLOBEY-mAbs Names Michael Rossi as President and Chief Executive..
      10/18/202309:00EDGAR2Form 8-K - Current report
      10/17/202318:01DJNY-mAbs Therapeutics New Drug Application Gets FDA Clearance
      10/17/202316:05GLOBEY-mAbs Therapeutics Announces U.S. FDA Clearance of..

      Your Recent History

      NASDAQ
      YMAB
      Y mAbs Therapeutics
      Delayed Upgrade Clock